Harris Melody
Known title: President, Enterprise OpsCIK: 0001880847
Associated companies
Transaction History
| NEO | ▼ Sell | Tax Withholding | 2,056 | $0 | 2/23/2025 | View on chart |
| NEO | ▲ Buy | Option Exercise | 8,443 | $0 | 2/23/2025 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 7,070 | $0 | 1/1/2025 | View on chart |
| NEO | ▲ Buy | Option Exercise | 7,068 | $0 | 5/11/2024 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 1,722 | $26K | 5/11/2024 | View on chart |
| NEO | ▼ Sell | Tax Withholding | 7,123 | $0 | 1/1/2024 | View on chart |
| NEO | ▲ Buy | Grant | 108,225 | $0 | 1/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
NeoGenomics Shares Drop 12% on CEO Transition News
NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.
NeoGenomics Shares Drop 12% on CEO Transition News. NeoGenomics stock fell 12% following the announcement of a CEO succession plan, despite reporting a revenue beat and a strong Q3 outlook. The market reaction highlights how leadership changes can outweigh immediate financial results. Analysts remain mixed, with StoneX raising its price target to $20 while the average target sits at $21.55.